Agios Pharmaceuticals, Inc. (AGIO)
33.34
-0.30
(-0.89%)
USD |
NASDAQ |
Sep 11, 13:46
Agios Pharmaceuticals Gross Profit (TTM) : 85.11M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.11M |
| March 31, 2026 | 54.21M |
| December 31, 2025 | 42.51M |
| September 30, 2025 | 33.79M |
| June 30, 2025 | 30.80M |
| March 31, 2025 | 26.83M |
| December 31, 2024 | 26.68M |
| September 30, 2024 | 23.69M |
| June 30, 2024 | 22.00M |
| March 31, 2024 | 17.61M |
| December 31, 2023 | 12.06M |
| September 30, 2023 | 6.462M |
| June 30, 2023 | -0.176M |
| March 31, 2023 | -0.945M |
| December 31, 2022 | -6.023M |
| September 30, 2022 | -10.15M |
| June 30, 2022 | -13.24M |
| March 31, 2022 | -18.30M |
| December 31, 2021 | -18.78M |
| September 30, 2021 | -19.05M |
| June 30, 2021 | -19.04M |
| March 31, 2021 | -18.99M |
| December 31, 2020 | -18.77M |
| September 30, 2020 | 17.11M |
| June 30, 2020 | 43.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 69.50M |
| December 31, 2019 | 99.98M |
| September 30, 2019 | 96.38M |
| June 30, 2019 | 87.67M |
| March 31, 2019 | 65.91M |
| December 31, 2018 | 40.11M |
| September 30, 2018 | 12.71M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Biogen, Inc. | 6.211B |
| Insmed, Inc. | 941.78M |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |